Neutrophil/Leukemia‐Tropic Dual‐Drug Nanomedicine Potentiates the Treatment of Acute Myeloid Leukemia

Documenti analoghi

• Systemic Multifunctional Nanovaccines for Potent Personalized Immunotherapy of Acute Myeloid Leukemia
  di: Peng Zhang, et al.
  Pubblicazione: (2024)
• Leukemia Cell Hitchhiking Hypoxia Responsive Nanogel for Improved Immunotherapy of Acute Myeloid Leukemia
  di: Haoting Chen, et al.
  Pubblicazione: (2024)
• CD123 Targeted Epigenetic Nanotherapy for Fusion Oncoprotein MLL‐AF9 Rearranged Acute Myeloid Leukemia in Preclinical and Patient Derived Xenograft Models
  di: Avinash Chandra Kushwaha, et al.
  Pubblicazione: (2025)
• Neutrophil Membrane‐Camouflaged Polyprodrug Nanomedicine for Inflammation Suppression in Ischemic Stroke Therapy
  di: Ya Zhao, et al.
  Pubblicazione: (2024)
• Nanomedicine Targeting Myeloid‐Derived Suppressor Cells Enhances Anti‐Tumor Immunity
  di: En‐Li Yang, et al.
  Pubblicazione: (2024)